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PURPOSE: Biological explanations for discrepancies in patients related response to
chemotherapy depending on the underlying oncogenic events is a promising research
area. TLX1 or TLX3 deregulated T-ALLs (TLX1/3+) share an immature cortical
phenotype and similar transcriptional signatures. However, their prognostic impacts
differ and inconsistent clinical outcome has been reported for TLX3. We therefore
hypothesized that the overlapping transcriptional profiles of TLX1+ and TLX3+ T-
ALLs would allow identification of candidate genes which might determine their
distinct clinical outcomes.
EXPERIMENTAL DESIGN: We compared TLX1+ and TLX3+ adult T-ALL outcome in
the successive French national LALA-94 and GRAALL-2003/2005 multicentric trials
and analyzed transcriptomic data to identify differentially expressed genes. Epigenetic
regulation of and L-asparaginase sensitivity were evaluated for T-ALL cell-lines and
primary samples.
RESULTS: We show that TLX1+ patients expressed low levels of Asparagine
Synthetase () when compared to TLX3+ and TLX negative patients, due to epigenetic
silencing of by both DNA methylation and a decrease of active histone marks.
Promoter methylation of the gene correlated with L-asparaginase sensitivity in both T-
ALL cell lines and Patient Derived Xenografts. Finally, promoter methylation was an
independent prognostic factor for both EFS (HR, 0.42 [95% CI, 0.24 to 0.71],
p=0.001) and OS (HR, 0.40 [95% CI, 0.23 to 0.70], p=0.02) in 160 GRAALL2003/2005
T-ALL patients and also in an independent series of 47 LL03 treated T lymphoblastic
lymphomas (p=0.012).
CONCLUSIONS: We conclude that methylation status at diagnosis may allow
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